Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helga Westerlind

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Journal of Internal Medicine|September 27, 2022
Familial autoimmunity in patients with idiopathic inflammatory myopathiesWeng Ian Che, Helga Westerlind, Ingrid E Lundberg, et al.
Journal of Neurology|December 23, 2018
Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide studyJie Song, Helga Westerlind, Kyla A McKay, et al.
Brain : a Journal of Neurology|January 21, 2014
Modest familial risks for multiple sclerosis: a registry-based study of the population of SwedenHelga Westerlind, Ryan Ramanujam, Daniel Uvehag, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2023
Familial Co-Aggregation of Idiopathic Inflammatory Myopathies and Cancer: A Swedish Population-Based StudyWeng Ian Che, Fredrik Baecklund, Karin Hellgren, et al.
RMD Open|April 15, 2025
In early rheumatoid arthritis, comorbidities do not explain the increased risk of failure to reach remission in patients with obesityLiselotte Tidblad, Anton Öberg Sysojev, Bénédicte Delcoigne, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 4, 2012
Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practiceRoger Jungedal, Malin Lundkvist, Elin Engdahl, et al.
Annals of the Rheumatic Diseases|March 25, 2017
Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-upVivek Anand Manivel, Mohammed Mullazehi, Leonid Padyukov, et al.
Journal of Internal Medicine|August 2, 2024
Impact of cancer on the mortality of patients with idiopathic inflammatory myopathies by flexible parametric multistate modellingWeng Ian Che, Ralf Kuja-Halkola, Karin Hellgren, et al.
Arthritis Care & Research|April 4, 2017
Dietary Intake of Polyunsaturated Fatty Acids and Pain in Spite of Inflammatory Control Among Methotrexate-Treated Early Rheumatoid Arthritis PatientsCecilia Lourdudoss, Daniela Di Giuseppe, Alicja Wolk, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 18, 2020
Respiratory Diseases as Risk Factors for Seropositive and Seronegative Rheumatoid Arthritis and in Relation to SmokingVanessa L Kronzer, Helga Westerlind, Lars Alfredsson, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Journal of Internal Medicine|September 27, 2022
Familial autoimmunity in patients with idiopathic inflammatory myopathiesWeng Ian Che, Helga Westerlind, Ingrid E Lundberg, et al.
Journal of Neurology|December 23, 2018
Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide studyJie Song, Helga Westerlind, Kyla A McKay, et al.
Brain : a Journal of Neurology|January 21, 2014
Modest familial risks for multiple sclerosis: a registry-based study of the population of SwedenHelga Westerlind, Ryan Ramanujam, Daniel Uvehag, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2023
Familial Co-Aggregation of Idiopathic Inflammatory Myopathies and Cancer: A Swedish Population-Based StudyWeng Ian Che, Fredrik Baecklund, Karin Hellgren, et al.
RMD Open|April 15, 2025
In early rheumatoid arthritis, comorbidities do not explain the increased risk of failure to reach remission in patients with obesityLiselotte Tidblad, Anton Öberg Sysojev, Bénédicte Delcoigne, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 4, 2012
Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practiceRoger Jungedal, Malin Lundkvist, Elin Engdahl, et al.
Annals of the Rheumatic Diseases|March 25, 2017
Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-upVivek Anand Manivel, Mohammed Mullazehi, Leonid Padyukov, et al.
Journal of Internal Medicine|August 2, 2024
Impact of cancer on the mortality of patients with idiopathic inflammatory myopathies by flexible parametric multistate modellingWeng Ian Che, Ralf Kuja-Halkola, Karin Hellgren, et al.
Arthritis Care & Research|April 4, 2017
Dietary Intake of Polyunsaturated Fatty Acids and Pain in Spite of Inflammatory Control Among Methotrexate-Treated Early Rheumatoid Arthritis PatientsCecilia Lourdudoss, Daniela Di Giuseppe, Alicja Wolk, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 18, 2020
Respiratory Diseases as Risk Factors for Seropositive and Seronegative Rheumatoid Arthritis and in Relation to SmokingVanessa L Kronzer, Helga Westerlind, Lars Alfredsson, et al.
Pageof 7